Good Laboratory Practices (GLP)

Mastering Good Laboratory Practices (GLP) in Pharma: Ensuring Data Integrity and Compliance

GLP refers to a quality system concerned with the organizational processes and conditions under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, archived, and reported. It…

GLP Non-Conformances? Lab Quality System Solutions

Identifying symptoms of GLP non-conformances early is crucial for maintaining compliance and preventing further issues. Common indicators include:Click to read the full article.

Deviation handling weak during sponsor oversight – preventing repeat GLP findings

Identifying symptoms or signals indicative of weak deviation handling is the first step towards a robust response. Symptoms might manifest as:Click to read the full article.

Test article accountability issue during routine studies – inspection deficiency risk analysis

Recognizing symptoms of test article accountability issues is the first line of defense in preventing inspection deficiencies. The following signals can indicate potential problems:Click to read the full article.

Archival process non-compliant during internal audit – evidence package inspectors expect

Recognizing the early signs of non-compliance in archival processes involves diligent monitoring and observation. Key symptoms that may indicate issues include:Click to read the full article.

Archival process non-compliant during sponsor oversight – evidence package inspectors expect

Identifying signs of archival process non-compliance early can mitigate risks and streamline corrective actions. Common symptoms to watch for include:Click to read the full article.

GLP study documentation gaps during internal audit – alignment with OECD principles

Early detection of potential GLP study documentation gaps can save resources and reduce the risk of non-compliance during inspections. Below are indicators that may signal existence of documentation issues:Click to…

Archival process non-compliant during routine studies – CAPA for GLP system gaps

Identifying symptoms of archival process non-compliance is crucial for timely intervention. Key symptoms may include:Click to read the full article.

Archival process non-compliant during study reconstruction – CAPA for GLP system gaps

Detecting signs of non-compliance starts with understanding what to look for on the production floor or in the laboratory environment. Common symptoms that may indicate issues with the archival process…

GLP study documentation gaps during regulatory inspection – preventing repeat GLP findings

Addressing GLP Study Documentation Deficiencies During Regulatory Inspections In the pharmaceutical industry, ensuring compliance with Good Laboratory Practices (GLP) is essential for maintaining product integrity and regulatory compliance. GLP study…

Raw data traceability failure during study reconstruction – inspection deficiency risk analysis

Identifying symptoms of raw data traceability failure is the first step in the problem-solving process. Signs may include:Click to read the full article.

Raw data traceability failure during routine studies – alignment with OECD principles

Effective monitoring starts with recognizing potential indicators of raw data traceability failures. Key symptoms include:Click to read the full article.